CLARK IAN T
SEC insider (Form 3/4/5 filer). CIK 0001336504. Director at Guardant Health, Inc. (GH) and 6 other issuers. 39 reported Form 4/5 transactions since Sep 2024; latest on Aug 4, 2026. Located in PALO ALTO, CA.
Companies CLARK IAN T has filed insider reports for
- Guardant Health, Inc. (GH): Director
- Olema Pharmaceuticals, Inc. (OLMA): Director
- Corvus Pharmaceuticals, Inc. (CRVS): Director
- BIOMARIN PHARMACEUTICAL INC (BMRN): Director
- Kyverna Therapeutics, Inc. (KYTX): Director
- TAKEDA PHARMACEUTICAL CO LTD (TAK): Director
- GoodRx Holdings, Inc. (GDRX): Director
CLARK IAN T
CIK: 0001336504
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (39 total)
- Aug 4, 2026GH
Guardant Health, Inc.
ExerciseIndirect2.3K shares at avg. $91.11$205K - Aug 4, 2026GH
Guardant Health, Inc.
SaleIndirect5.1K shares at avg. $158.80$809K - Aug 4, 2026GH
Guardant Health, Inc.
ExerciseIndirect6.8K shares at avg. $50.57$346K - Aug 4, 2026GH
Guardant Health, Inc.
SaleIndirect9.1K shares at avg. $158.98$1.4M - Jun 18, 2026OLMA
Olema Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
29.5K shares- - Jun 17, 2026GH
Guardant Health, Inc.
ExerciseIndirect5.1K shares- - Jun 17, 2026GH
Guardant Health, Inc.
AwardDirectRestricted Stock Units
2.7K shares- - Jun 11, 2026CRVS
Corvus Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
15K shares- - Jun 2, 2026BMRN
BIOMARIN PHARMACEUTICAL INC
AwardDirect7.5K shares- - May 27, 2026KYTX
Kyverna Therapeutics, Inc.
AwardDirect5.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 4, 2026 |  GH Guardant Health, Inc. | Exercise | 2,255 | $91.11 | $205,453 | Indirect |
| Aug 4, 2026 | GH Guardant Health, Inc. | Sale | 5,092 | $158.80 | $808,626 | Indirect |
| Aug 4, 2026 | GH Guardant Health, Inc. | Exercise | 6,833 | $50.57 | $345,545 | Indirect |
| Aug 4, 2026 | GH Guardant Health, Inc. | Sale | 9,088 | $158.98 | $1,444,825 | Indirect |
| Jun 18, 2026 |  OLMA Olema Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 29,500 | - | - | Direct |
| Jun 17, 2026 | GH Guardant Health, Inc. | Exercise | 5,092 | - | $0 | Indirect |
| Jun 17, 2026 | GH Guardant Health, Inc. | Award Restricted Stock Units | 2,711 | - | - | Direct |
| Jun 11, 2026 |  CRVS Corvus Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 15,000 | - | - | Direct |
| Jun 2, 2026 |  BMRN BIOMARIN PHARMACEUTICAL INC | Award | 7,490 | - | $0 | Direct |
| May 27, 2026 |  KYTX Kyverna Therapeutics, Inc. | Award | 5,093 | - | $0 | Direct |
1-10 of 39 transactions